In triple-negative breast cancer cells MDA-MB-231, MVP has been demonstrated to be upregulated by the Notch1 intracellular domain and the activation of the AKT pathway and promoting the epithelial-to-mesenchymal transition (EMT) and the chemoresistance of cancer cells (65). This evidence concerns the gene AKT1 and cancer.